BOCH
Blue Owl Capital Holdings Portfolio holdings
AUM $310M
1-Year Return
6.98%
This Quarter Return
+5.55%
1 Year Return
+6.98%
3 Year Return
+59.66%
5 Year Return
–
10 Year Return
–
AUM
$418M
AUM Growth
+$289M
(+224%)
Cap. Flow
+$287M
Cap. Flow
% of AUM
68.61%
Top 10 Holdings %
Top 10 Hldgs %
73.32%
Holding
45
New
30
Increased
2
Reduced
1
Closed
2
Top Buys
| 1 |
Pliant Therapeutics
PLRX
|
+$54.4M |
| 2 |
Cullinan Oncology
CGEM
|
+$34.8M |
| 3 |
Tourmaline Bio
TRML
|
+$32.4M |
| 4 |
Repare Therapeutics
RPTX
|
+$22.8M |
| 5 |
SLRN
ACELYRIN
SLRN
|
+$17.1M |
Top Sells
| 1 |
Starwood Property Trust
STWD
|
+$2.13M |
| 2 |
GitLab
GTLB
|
+$1.2M |
| 3 |
FATH
Fathom Digital Manufacturing Corporation
FATH
|
+$223K |
Sector Composition
| 1 | Healthcare | 66.67% |
| 2 | Financials | 20.39% |
| 3 | Technology | 11.87% |
| 4 | Industrials | 0.19% |
| 5 | Real Estate | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Pliant Therapeutics
PLRX
$93.9M
| $54.4M | 13.01% |
+3,004,199
| New | +$54.4M |
|
2
Robinhood
HOOD
$103B
| $54M | 12.9% |
4,237,409
| – | – |
|
|
3
Cullinan Oncology
CGEM
$380M
| $34.8M | 8.33% |
+3,419,842
| New | +$34.8M |
|
|
4
Tourmaline Bio
TRML
$1.23B
| $32.4M | 7.74% |
+1,332,302
| New | +$32.4M |
|
5
Klaviyo
KVYO
$9.57B
| $31.5M | 7.52% |
1,198,270
| – | – |
|
6
Blue Owl Capital
OBDC
$6.98B
| $30.2M | 7.22% |
2,045,070
| – | – |
|
|
7
Repare Therapeutics
RPTX
$76.5M
| $22.8M | 5.45% |
+3,122,499
| New | +$22.8M |
|
|
SLRN
8
DELISTED
ACELYRIN
SLRN
| $17.1M | 4.09% |
+2,292,990
| New | +$17.1M |
|
9
Larimar Therapeutics
LRMR
$334M
| $15.5M | 3.71% |
+3,414,468
| New | +$15.5M |
|
10
Keros Therapeutics
KROS
$643M
| $14M | 3.35% |
+352,633
| New | +$14M |
|
11
Ultragenyx Pharmaceutical
RARE
$2.85B
| $12.6M | 3.01% |
+263,238
| New | +$12.6M |
|
12
enGene Holdings
ENGN
$312M
| $11.4M | 2.72% |
+1,234,760
| New | +$11.4M |
|
|
SYRS
13
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $8.46M | 2.02% |
+1,493,252
| New | +$8.46M |
|
14
Disc Medicine
IRON
$2.08B
| $8.1M | 1.94% |
+140,260
| New | +$8.1M |
|
|
ETWO
15
DELISTED
E2open Parent Holdings
ETWO
| $7.25M | 1.73% |
1,650,943
| – | – |
|
|
BPMC
16
DELISTED
Blueprint Medicines
BPMC
| $6.63M | 1.59% |
+71,888
| New | +$6.63M |
|
17
Toast
TOST
$23.1B
| $6.04M | 1.44% |
5,890,274
+5,567,696
| +1,726% | +$5.71M |
|
|
INZY
18
DELISTED
Inozyme Pharma
INZY
| $5.41M | 1.29% |
+1,270,027
| New | +$5.41M |
|
19
Mineralys Therapeutics
MLYS
$2.82B
| $4.89M | 1.17% |
+568,379
| New | +$4.89M |
|
20
Compass Therapeutics
CMPX
$630M
| $4.41M | 1.06% |
+2,829,712
| New | +$4.41M |
|
21
MoonLake Immunotherapeutics
MLTX
$3.4B
| $3.93M | 0.94% |
+65,000
| New | +$3.93M |
|
|
IMA
22
ImageneBio, Inc. Common Stock
IMA
$96.1M
| $3.85M | 0.92% |
+162,801
| New | +$3.85M |
|
23
Direxion Daily S&P Biotech Bear 3X Shares
LABD
$82.6M
| $3.29M | 0.79% |
+340,000
| New | +$3.29M |
|
|
OMGA
24
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $3.18M | 0.76% |
+1,055,882
| New | +$3.18M |
|
25
Ovid Therapeutics
OVID
$91.7M
| $2.78M | 0.67% |
+864,822
| New | +$2.78M |
|